Project Grant R50CA292022
Award Date 9/1/25
Completion Date 8/31/29
Dollars Obligated $362K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Oklahoma City, OK, USA
Similar Awards
- The University of Oklahoma Health Sciences Center (OUHSC) was awarded a $424,480 federal Project Grant by the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395). The grant, awarded on September 11, 2025, will fund research initiatives aimed at improving lung cancer care and outcomes in Oklahoma, where lung cancer mortality rates are higher than the national average. The principal investigator, a thoracic medical oncologist, will use the grant funding to...
- This federal Project Grant award, funded by the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395), supports efforts by a Columbia University researcher to develop and implement NCI-sponsored cancer clinical trials at the NCI-designated Herbert Irving Comprehensive Cancer Center (HICCC). The $193,926 award, with a project period from September 1, 2025 to August 31, 2030, will enable the researcher to: (1) develop novel HICCC investigator-led trials for...
- This $575,051 Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will support the University of Arizona Cancer Center (UACC) in enhancing its NCI-funded clinical research enterprise over a 5-year period from September 1, 2025 to August 31, 2030. The key objectives are to grow the breadth of the UACC's clinical trial portfolio to better serve its diverse patient population, increase accruals to interventional treatment trials (especially NCI-sponsored...
- The National Cancer Institute (NCI) awarded a $211,628 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the University of Oklahoma Health Sciences Center (OUHSC) to establish the Cancer Undergraduate Research Experience (CURE) program in Oklahoma. The CURE program aims to address Oklahoma's high cancer incidence and mortality rates by providing high-quality cancer research training experiences for undergraduate students to prepare them for graduate programs and careers...
- This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides funding to The Trustees of the University of Pennsylvania to support the development and implementation of NCI-sponsored clinical trials for rare cancers. The $122,610 award, which began in August 2025, aims to: Assist junior and mid-career oncology faculty in developing investigator-initiated studies, and Develop a program within the National Clinical Trials Network (NCTN) to design...
- This Project Grant award of $326,103 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports research by the University of Oklahoma Health Sciences Center to investigate the role of protein-nanoparticle interactions in understanding the multicellular crosstalk within the tumor microenvironment of ovarian and pancreatic cancers. The research aims to decipher the domains of the protein IGFBP2 that are responsible for driving this multicellular crosstalk, and to...
- The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) has been awarded a $135,951 Project Grant from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to enhance access to breast cancer prevention clinical trials. The project aims to modernize engagement and delivery of cancer prevention research, with a focus on improving recruitment and representation of all populations in breast cancer prevention trials. The award supports research initiatives to...
- The National Cancer Institute (NCI) awarded a Project Grant of $375,025 to the University of Maryland, Baltimore under the Cancer Treatment Research federal grant program (CFDA 93.395). The grant supports Dr. Mark Mishra, who plays a critical role in the University of Maryland Greenebaum Comprehensive Cancer Center's clinical trials program and NCI-funded research. The key goals of the award are to: 1) Expand access to NCI-sponsored clinical trials at new network sites; 2) Foster partnerships to...
- This federal Project Grant award, valued at $682,272.00, was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The award will fund a research project entitled "Assessing Feasibility and Acceptability of a Multifaceted EHR-Integrated Mobile Health Intervention Following Radical Cystectomy" at the University of Michigan. The goal of the project is to develop and evaluate a novel, technology-enabled intervention to reduce...
- The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the University of Oklahoma Health Sciences Center to conduct a randomized factorial trial on smoking cessation interventions. The $625,201 award, effective January 1, 2025 through December 31, 2029, will evaluate the combined impact of varenicline medication plus nicotine lozenges, and a smartphone-based medication adherence intervention, on 7-day point prevalence...